Trial NCT00441168

View at ClinicalTrials.gov 
Org. Study IDs: CR011065
Secondary IDs: 2006-001709-27 26866138MMY2038

Last trial update was posted on 2014-03-21

MeSH Interventions

Bortezomib Dexamethasone Doxorubicin Liposomal doxorubicin Vincristine

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

TRIAL STOPPED due to a change in standard of care and the required patient numbers could no longer be achieved

Limitations And Caveats

Due to a substantial decline in the use of the VAD regimen as standard of care, recruitment of the study was halted at 30 subjects. It was not possible to statistically evaluate any long term efficacy parameter.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID